.After revealing a period 3 launch based upon positive midstage outcomes, iTeos and also GSK are ult...
.The FDA ought to be actually extra available and also joint to unleash a surge in commendations of ...
.It's an extraordinarily active Friday for biotech IPOs, with Zenas BioPharma, MBX and Bicara Therap...
.Atea Pharmaceuticals' antiviral has fallen short another COVID-19 test, yet the biotech still keeps...
.Neurocrine Biosciences' mental illness program pivot has actually failed. The biotech was incapable...
.Sanofi has made an overdue access to the radioligand event, paying out one hundred million european...
.After F2G's 1st try to obtain a new class of antifungal to market was derailed due to the FDA, the ...
.Moderna has actually vowed to cut R&D investing through $1.1 billion through 2027. The choice to...
.Just four months after Sanofi wager $80 thousand in ahead of time money on Pivot Therapeutics' losm...
.Cancer company Oncternal Therapeutics is actually folding all its own medical tests and giving up s...